CERE
Complex mixture of neuropeptides derived from pig brain. Used in Europe and Asia for stroke and cognitive disorders.
Regulatory status (as of Sept 2026)
Not FDA-approved and not available as a US compounded product; not on the April 2026 503A Category 2 removal list or the July 2026 PCAC agenda. Importing it for personal use is not a lawful pathway.
See the FDA peptide regulatory tracker · Read our July 27, 2026 dispatch on the FDA PCAC peptide vote3 studies referenced · Last reviewed Oct 1, 2026 · Reviewed by The Peptide Dispatch Editorial Team · How we research & label content
Cerebrolysin is approved as a medicine in some countries outside the US, but not by the FDA. Complex mixture of neuropeptides derived from pig brain.
| Half-life | Not established in published research |
|---|---|
| How it's given in studies | IV or IM injection |
| Research stage | Approved outside US |
| Dosing | Published research: 30 mL/day IV for 21 days starting 24-72 h after stroke onset, alongside standardized rehabilitation (CARS… details30 mL/day IV for 21 days starting 24-72 h after stroke onset, alongside standardized rehabilitation (CARS randomized placebo-controlled trial)Community-reportedCommunity-reported: 5–30 mL IV, IV or IM injection |
Published-research dosing is what was given in the cited studies (species and units as reported). Community-reported dosing is what users describe, not from clinical studies. Neither is a recommendation. Not medical advice.
Where each point comes from: Clinicalhuman trials and FDA labels Lab / animalrodent, cell and ex vivo studies Community-reporteduser experience and commonly used protocols, not from clinical studies
In plain terms: It is a mix of pig-brain peptides thought to support nerve cells, but studies have not shown clear benefits in stroke patients. Proposed mechanism, from preclinical work: a peptide mixture derived from pig brain, described as having neurotrophic activity (neuroplasticity, neuroprotection, neurogenesis); these are not demonstrated clinical effects. In acute ischaemic stroke, Cochrane reviews found it probably has little or no beneficial effect on all-cause death, with a potential increase in non-fatal serious adverse events (Ziganshina 2020, 2023).
How to read this: Each item below is an effect observed in research subjects in the cited studies — think of Dexter, our stand-in research subject. These are findings from the literature, not results you should expect, and not medical advice.
Community-reportedIn user communities, Cerebrolysin is typically run at 5–30 mL (IV or IM injection). This is not a recommendation.
Community reports are anecdotal, vary widely in product quality and purity, and are not medical advice. Talk to a licensed provider.
New research, FDA peptide updates, and what users are reporting. One email a week. Unsubscribe anytime.
| Peptide | Half-Life | Route | Research Status |
|---|---|---|---|
| Cerebrolysin | No published PK data found | IV or IM injection | Approved outside US |
| Cortexin | No published PK data found | Intramuscular injection | Approved outside US |
| Oxytocin | 3-5 minutes (but effects longer) | Intranasal | FDA-approved |
| Thymulin (Zn-FTS) | Unknown | Subcutaneous injection | Preclinical (animal) |
| VIP (Vasoactive Intestinal Peptide) | ~2 minutes | Intranasal or subcutaneous | Phase 3 |
Values reflect figures reported in published research. Compare any peptides side-by-side →
This peptide belongs to the Research category. View All Research Peptides
Cognitive
From Our Affiliated Clinic
1836 Wellness is a physician-supervised clinic in Houston, TX. Discussing a compound on this page is not an offer to prescribe or supply it.
See how it works →Disclosure: The Peptide Dispatch and 1836 Wellness are commonly owned by 1836 Wellness LLC. We may benefit financially if you become a client of 1836 Wellness. Learn more.
Dosing, half-life figures, and mechanism descriptions on this page are compiled from peer-reviewed published research, with the species and study type stated where reported. Figures labeled “Dosing used in published research” describe what was given in those studies and do not constitute dosing recommendations for any human use. Each cited paper is listed with DOI and PubMed links in the References section above. Found an error? Contact us.